TRITENVA owner Contact Information online
from Aventis Pharma S.A.
TRITENVA
US serial number:85134352
Application filling date:Sep. 21, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Mar. 01, 2011
Publication date:Dec. 14, 2010
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Foreign foreign registration number:03/3215574
Foreign foreign registration date:Mar. 17, 2003
Foreign foreign application registration country:FRANCE
Foreign foreign expiration date:Mar. 17, 2013
Goods and services:For: pharmaceutical preparations for the prevention and treatment of cardiovascular diseases, thrombosis, diseases of the central nervous system, cancer, diabetes, and respiratory diseases; pharmaceutical preparations for the prevention and treatment of i
Current owner owner name:Aventis Pharma S.A.
Current owner owner address:20, avenue Raymond Aron
92160 Antony
FRANCE
Current owner legal entity type:CORPORATION
Current owner state or country:FRANCE
Attorney name:Susan Upton Douglass
Attorney email:sdouglass@frosszelnick.com
Attorney docket number:AVPS 1005434
Attorney email authorized:No
Correspondent name address:SUSAN UPTON DOUGLASS
FROSS ZELNICK LEHRMAN & ZISSU, P.C.
866 UNITED NATIONS PLZ
NEW YORK,
NEW YORK
UNITED STATES
10017-1822
Correspondent phone:212-813-5900
Correspondent email:sdouglass@frosszelnick.com
Correspondent fax:212-813-5901
Correspondent email authorized:No
Domestic representative name:Susan Upton Douglass
Domestic representative phone:212-813-5900
Domestic representative fax:212-813-5901
Domestic representative email:sdouglass@frosszelnick.com
Domestic representative email authorized TRITENVA:Yes
Latest trademarks
Popular owners
Glaxo Group Limited (173) JOHNSON & JOHNSON (133) Novartis AG (130) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) Pfizer Inc. (41) SANOFI (41) Wyeth LLC (41) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Dec. 14, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
